Maternal diazepam exposure on brain ornithine decarboxylase and growth of offspring.
The prenatal treatment of diazepam on the developmental pattern of brain ornithine decarboxylase and the general growth of offspring were studied. Diazepam (120 mg/kg/day) was administered orally to pregnant Sprague-Dawley rats from day 14 to day 20 of gestation. The activity of brain ornithine decarboxylase and body weight of the offspring were measured from the late fetal stage to the early postnatal stage. It was found that diazepam inhibited both the prenatal and 4-hour postnatal ornithine decarboxylase activities, though the general maturation pattern of the enzyme in the brain was not much altered. It may indicate that diazepam inhibits early brain development. The enzyme activity fell off as it reached maturation. Prenatal treated neonates of 6-hour or older age group had the normal activities of brain ornithine decarboxylase. The general growth of the treated offspring was substantially retarded. Their body weights were very much lower than the control offspring. The results of the present study is an additional evidence that diazepam and other benzodiazepines should be used with great care in pregnant women.
D000375:Aging; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000196:embryology* / Q000254:growth & development; D002250:Carbon Radioisotopes; D003975:Diazepam / Q000494:pharmacology*; D005260:Female; D008431:Maternal-Fetal Exchange; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains
D002250:Carbon Radioisotopes; D009955:Ornithine Decarboxylase; D003975:Diazepam